Clinical and Experimental Pharmacology and Physiology is a broad scope pharmacology journal aiming to advance the translation of basic research to clinical practice. The journal covers clinical and experimental pharmacology and physiology, blood pressure, cardiovascular disease, heart failure, pharmacokinetics, toxicology, and more.

Journal Metrics

  • 5.5CiteScore
  • 2.5Journal Impact Factor
  • 12%Acceptance rate
  • 5 days Submission to first decision
view all metrics

Articles

ORIGINAL ARTICLE

Sinomenine Suppresses Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting O-GlcNAcylation of SP1

  •  17 July 2025

Graphical Abstract

Sinomenine Suppresses Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting O-GlcNAcylation of SP1 Issue 9, 2025

The anti-tumour efficacy of SIN in HCC by suppressing the malignant processes of HCC cells. Mechanistically, SIN upregulated OGA expression to block the O-GlcNAcylation of SP1 and thus decrease the protein stability of SP1. All these findings reveal a novel potential therapeutic target of SIN for HCC patients.

ORIGINAL ARTICLE

M2 Macrophages-Derived Exosomes Inhibited Podocyte Pyroptosis via lncRNA AFAP1-AS1/EZH2 Axis

  •  15 July 2025

Graphical Abstract

M2 Macrophages-Derived Exosomes Inhibited Podocyte Pyroptosis via lncRNA AFAP1-AS1/EZH2 Axis Issue 9, 2025

This study revealed that exosomes derived from M2 macrophages inhibited podocyte pyroptosis via transferring AFAP1-AS1 to podocytes. Mechanistically, AFAP1-AS1 interacted with EZH2 to transcriptionally regulate H3K27me3 level in the NLRP3 promoter region, thus epigenetically repressing NLRP3 expression to inhibit podocyte pyroptosis. Our findings provided a potential molecular target for the therapeutic interventions of diabetic nephropathy.

ORIGINAL ARTICLE
Open access

Potential Kidney Risks Associated With Clinical Doses of Omeprazole: In Vivo and In Vitro Studies

  •  7 July 2025

Graphical Abstract

Potential Kidney Risks Associated With Clinical Doses of Omeprazole: In Vivo and In Vitro Studies Issue 8, 2025

Omeprazole decreases cell proliferation and viability by disrupting gene expression; thus, the long-term use of omeprazole may increase inflammation and environmental susceptibility. These findings provide valuable insights for the clinical use of omeprazole, highlighting the need for careful consideration of its effects in the kidney.

ORIGINAL ARTICLE

Decrease in Mitochondrial Oxidative Respiratory Function in Liver of Cricetulus barabensis Under Long and Short Photoperiods: The Role of Mitochondrial Fission and Apoptosis

  •  30 June 2025

Graphical Abstract

Decrease in Mitochondrial Oxidative Respiratory Function in Liver of Cricetulus barabensis Under Long and Short Photoperiods: The Role of Mitochondrial Fission and Apoptosis Issue 8, 2025

Graphical summary of the study: CS, citrate synthase; DRP1, dynamin-related protein 1; FIS1, fission 1; SP, short photoperiod; LP, long photoperiod; MFF, mitochondrial fission factor.

ORIGINAL ARTICLE

Frailty: An Important Determinant Influencing Glycaemic Control in Elderly Chinese Patients Diagnosed With Type 2 Diabetes

  •  29 June 2025

Graphical Abstract

Frailty: An Important Determinant Influencing Glycaemic Control in Elderly Chinese Patients Diagnosed With Type 2 Diabetes Issue 8, 2025

In a cross-sectional study of 1150 Chinese type 2 diabetes patients (≥ 65 years), frailty, female sex, and insulin use were significantly associated with poor glucose control, identified through univariate and multivariate logistic regression analyses.

ORIGINAL ARTICLE

GPR39 Activation Attenuates AngII-Induced Abdominal Aortic Aneurysm by Suppressing ETS-1 Mediated VEGF-A/VEGFR2 Signalling

  •  29 June 2025

Graphical Abstract

GPR39 Activation Attenuates AngII-Induced Abdominal Aortic Aneurysm by Suppressing ETS-1 Mediated VEGF-A/VEGFR2 Signalling Issue 8, 2025

GPR39 activation by TC-G 1008 attenuates AngII-induced AAA in ApoE−/− mice by reducing oxidative stress (lowering MDA, increasing SOD/GSH) and suppressing VEGF-A/VEGFR2 signalling. The protective mechanism involves downregulation of the transcription factor ETS-1, which mediates VEGF-A/VEGFR2 expression and angiogenic tube formation in HUVECs. ETS-1 overexpression reverses TC-G 1008's effects, confirming its pivotal role in GPR39-mediated protection against AAA.

ORIGINAL ARTICLE

Synthesis, Characterization, Molecular Dynamic Simulation and Neuroprotective Effects of Synthetic Isoxazolone Derivatives in Ethanol‐Induced Neurodegeneration

  •  22 June 2025

Graphical Abstract

Synthesis, Characterization, Molecular Dynamic Simulation and Neuroprotective Effects of Synthetic Isoxazolone Derivatives in Ethanol-Induced Neurodegeneration Issue 8, 2025

This schematic workflow demonstrates the neuroprotective potential of isoxazolone derivatives by a series of studies starting from target identification to simulation, followed by in vitro and in vivo analysis, including behavioral, biochemical, and morphological studies.

ORIGINAL ARTICLE

Stachydrine Protects Against Cyclophosphamide-Induced Premature Ovarian Insufficiency in Wistar Rats by Inhibiting Oxidative Stress and Apoptosis via the Activation of the Nrf2/HO-1 Signalling Pathway

  •  22 June 2025

Graphical Abstract

Stachydrine Protects Against Cyclophosphamide-Induced Premature Ovarian Insufficiency in Wistar Rats by Inhibiting Oxidative Stress and Apoptosis via the Activation of the Nrf2/HO-1 Signalling Pathway Issue 8, 2025

Stachydrine (STA) inhibited cyclophosphamide (CP)-induced oxidative stress and apoptosis of granulosa cells by activating the Nrf2/HO-1 signalling pathway, thereby improving ovarian function and abnormal follicular development of CP-treated rats with premature ovarian insufficiency (POI).

ORIGINAL ARTICLE

Linarin Relieves Apoptosis, Inflammation and Oxidative Stress in LPS-Induced Acute Kidney Injury by Modulating COX2

  •  9 June 2025

Graphical Abstract

Linarin Relieves Apoptosis, Inflammation and Oxidative Stress in LPS-Induced Acute Kidney Injury by Modulating COX2 Issue 7, 2025

LIN interacted with COX2 to inhibit inflammation, apoptosis and oxidative stress in LPS-induced AKI.

ORIGINAL ARTICLE
Open access

A Novel Inhibitor of Methyltransferase SMYD2, AZ505 Protects Against Peritoneal Fibrosis in Mice

  •  25 May 2025

Graphical Abstract

A Novel Inhibitor of Methyltransferase SMYD2, AZ505 Protects Against Peritoneal Fibrosis in Mice Issue 7, 2025

AZ505, a highly selective inhibitor of SMYD2, may exhibit an antifibrotic effect in peritoneal fibrosis.

More articles
More articles
More articles

Latest news

Recent issues

Skip slideshow